Identifying Genuine Clinical Grade Bio-Remodellers vs. Fake Salon Copies

This article explains what bio-remodellers are, how they work within the skin, and what distinguishes regulated medical-grade products from imitation versions that may carry significant risks. It is intended as an educational resource to help you ask the right questions before pursuing any treatment.

Genuine clinical grade bio-remodellers are CE-marked or UKCA-registered medical devices or medicines, manufactured to strict pharmaceutical standards, and administered by qualified practitioners. Fake salon copies are often unregulated, unlicensed, or counterfeit products without verified safety data, correct formulation, or appropriate sterility standards — posing significant patient safety risks.

Bio-remodellers are injectable treatments designed to improve overall skin quality rather than simply add volume or target specific lines and wrinkles. Unlike traditional dermal fillers, their primary role is to stimulate the skin's own regenerative processes — encouraging improved hydration, increased collagen and elastin production, and improved skin laxity over time.

The most widely recognised bio-remodeller in the UK is Profhilo, which uses a high concentration of stabilised hyaluronic acid delivered via specific injection points across the face, neck, or hands. Other bio-remodelling treatments include polynucleotide (PDRN/PN) injectables such as Nucleofill and Plinest, and amino acid-based tissue stimulators such as Jalupro.

These treatments have become increasingly popular with patients who are looking to address early signs of skin ageing — including dullness, fine lines, reduced elasticity, and uneven skin texture — without dramatic volumisation. As with any injectable treatment, suitability varies between individuals and should always be assessed by a qualified practitioner during a formal consultation.

To understand why counterfeit or unregulated products present such a risk, it is helpful to understand how genuine bio-remodellers work at a cellular level.

Hyaluronic Acid and Skin Hydration

Hyaluronic acid (HA) is a naturally occurring molecule found throughout the body's connective tissues. Its primary biological role is to attract and retain water molecules, making it central to maintaining skin hydration, volume, and structural integrity. As we age, natural HA production declines, contributing to drier, thinner, and less resilient skin.

In genuine clinical grade products such as Profhilo, hyaluronic acid is thermally stabilised using a patented process (NAHYCO® technology) that produces a unique hybrid complex. This specific formulation allows the product to spread evenly within the skin rather than remaining in a localised deposit, triggering a biological response that encourages fibroblasts — the cells responsible for producing collagen, elastin, and other structural proteins — to increase their activity.

Polynucleotides and Tissue Regeneration

Polynucleotide bio-remodellers work differently. Derived from purified salmon or trout DNA, they interact with receptors on skin cells to promote tissue repair, reduce inflammation, and stimulate regenerative activity. This mechanism requires precise molecular weight, purity levels, and sterility that only properly regulated pharmaceutical manufacturing processes can reliably achieve.

Unregulated copies cannot guarantee any of these characteristics.

One of the most important steps a prospective patient can take is learning to recognise the markers of a legitimate, regulated product and the practitioner delivering it. The following distinguishing factors are worth understanding:

Regulatory Status

Genuine bio-remodellers available in the UK are either CE-marked medical devices (products placed on the market under EU MDD/MDR regulations before the UK's regulatory divergence) or carry UKCA marking, or are licensed medicines regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). Products such as Profhilo carry a valid CE mark and are distributed exclusively through licensed pharmaceutical wholesalers and authorised medical channels.

Salon copies, counterfeit products, and grey-market alternatives often lack any verifiable regulatory marking. They may display fabricated CE marks, reference unknown manufacturers, or be imported from unregulated overseas markets.

Manufacturer Transparency

Legitimate bio-remodeller brands such as IBSA (manufacturer of Profhilo), Mastelli (manufacturers of Plinest and Newest PN), and Pietro Lotti (manufacturer of Jalupro) are established pharmaceutical companies with verifiable manufacturing records, published clinical data, and established UK distribution networks.

Fake or copied products typically have opaque supply chains, unverifiable batch numbers, and no published peer-reviewed clinical evidence supporting their safety or efficacy.

Practitioner Qualification and Clinic Registration

Genuine clinical grade bio-remodellers should only be administered by qualified healthcare professionals — including doctors, dentists, nurses, or pharmacists with appropriate aesthetic training and indemnity. In England, from 2025 onwards under the Health and Care Act 2022 amendments, certain cosmetic procedures including injectable treatments require a registered healthcare professional to prescribe and deliver care.

If a product is being offered by an unqualified individual — for example in a beauty salon or at a home visit — or without any prescribing process, this is a significant warning sign regarding both the legitimacy of the product and the safety of the treatment environment.

Understanding warning signs can help patients protect themselves when researching treatments. The following factors should prompt further scrutiny or cause a patient to seek advice from a properly regulated clinic:

Significantly lower prices than those typically quoted by medical aesthetic clinics for recognised brand-name products

No named manufacturer or brand on the product packaging, or branding that closely mimics a well-known product with slight spelling variations

Unlabelled vials, syringes, or ampoules without batch numbers, expiry dates, or manufacturer details

Treatments offered without a prior consultation or suitability assessment

Practitioners without verifiable healthcare registration (practitioners can be checked via the GMC, NMC, GPhC, or GDC registers)

Claims of identical results to named clinical products at a fraction of the cost

No aftercare guidance or follow-up offered as part of the treatment package

Products described as "professional grade" or "salon grade" rather than carrying verifiable regulatory markings

None of these factors alone guarantees a product is unsafe or counterfeit, but they collectively represent meaningful reasons to ask more questions and consider seeking treatment only from a regulated clinical environment.

It would not be accurate to suggest that all cheaper or non-branded products are inherently dangerous — but the absence of regulatory oversight means there is no reliable way to verify their safety, sterility, or composition.

Sterility and Infection Risk

Injectable products that are not manufactured in properly controlled pharmaceutical environments may carry a risk of microbial contamination. Injecting contaminated material into the skin carries the potential for localised infection, abscess formation, or, in rare but serious cases, systemic infection. This risk is entirely separate from the skill of the practitioner.

Unknown Formulation

Without reliable manufacturing standards, it is impossible to confirm what an unregulated product contains, in what concentration, or how it will behave within the skin. Products claiming to contain hyaluronic acid or polynucleotides may contain subtherapeutic quantities, inappropriate molecular weights, or entirely different substances.

Immune and Inflammatory Reactions

Impurities or unidentified excipients within counterfeit products may trigger unpredictable inflammatory or immune responses. Granuloma formation — a chronic inflammatory reaction — is one recognised complication associated with non-medical grade injectable substances.

No Recourse in the Event of Complications

When complications arise from legitimate treatments administered by qualified practitioners, patients have access to aftercare, complication management, and professional accountability. With unregulated products and unqualified practitioners, patients may find themselves without appropriate medical support when problems occur.

Individuals who are curious about bio-remodelling treatments — whether for skin quality improvement, early signs of ageing, or general skin health maintenance — may find it helpful to seek a professional consultation. A qualified aesthetic practitioner can:

Assess your skin type, condition, and individual anatomy.

Explain which regulated products may be relevant to your concerns.

Discuss realistic expectations based on your skin's current condition.

Identify any contraindications or factors that might affect suitability.

Provide clear information about risks and aftercare requirements.

Patients who are considering skin rejuvenation treatments may particularly benefit from professional guidance, as the range of available options — and the variation in product quality — can be genuinely difficult to navigate without clinical expertise.

Seeking a consultation does not create any obligation to proceed with treatment. It is simply an opportunity to receive accurate, personalised information from a qualified professional. Patients comparing indications may also find a Profhilo treatment overview useful before discussing options in clinic.

Potential Benefits of Genuine Bio-Remodellers

When administered appropriately by qualified practitioners using regulated products, bio-remodellers may offer:

Improved overall skin hydration and plumpness.

Gradual enhancement of skin texture and tone.

Stimulation of collagen and elastin production over time.

A more rested or refreshed skin appearance.

Subtle improvement in mild skin laxity.

Results are typically gradual rather than immediate, becoming more noticeable after a course of treatments, and vary between individuals.

Realistic Limitations

Bio-remodellers are not appropriate for all skin concerns. They are generally considered more effective for improving overall skin quality than for addressing deep structural volume loss, significant facial asymmetry, or pronounced dynamic wrinkles. Results are not permanent and maintenance treatments are typically recommended.

Individual response to treatment varies based on factors including age, skin condition, lifestyle, sun exposure history, genetics, and overall health. No practitioner can guarantee specific outcomes. Where concerns include advanced laxity or deeper structural ageing, a medically led discussion about facial contouring options may help contextualise what bio-remodelling can and cannot achieve.

What Bio-Remodellers Cannot Do

It is important to maintain realistic expectations. Bio-remodellers do not produce the same results as surgical procedures, and are not a substitute for treatments targeting specific anatomical concerns. Patients are encouraged to have an honest, open conversation with their practitioner about what can and cannot be achieved.

Following any legitimate bio-remodelling treatment, practitioners will typically provide specific aftercare instructions tailored to the product used and the individual patient. General principles that may support outcomes and skin health include:

Sun protection: Daily application of a broad-spectrum SPF 30 or higher helps protect skin from UV-related collagen degradation and is considered one of the most evidence-supported measures in anti-ageing skincare.

Adequate hydration: Maintaining good general hydration supports skin function and overall health.

Gentle skincare in the immediate post-treatment period: Avoiding harsh exfoliants, active ingredients such as retinoids or AHAs, and excessive heat (saunas, steam rooms) immediately after treatment is generally advised.

Avoiding pressure on treated areas: Depending on the product and injection sites, practitioners may advise avoiding massage or pressure on treated areas for a short period.

Follow-up appointments: Many bio-remodelling protocols involve a series of treatments over several weeks, followed by periodic maintenance sessions.

Always follow the specific aftercare guidance provided by your treating practitioner rather than generalised online advice.

Clinical grade bio-remodellers are regulated medical products manufactured to pharmaceutical standards by verifiable companies with published safety data.

Counterfeit or unregulated salon copies lack the regulatory safeguards required to verify their safety, sterility, or actual composition.

Price should not be the primary deciding factor when researching injectable skin treatments — significantly lower costs may reflect an entirely different and potentially unsafe product.

Practitioner qualification matters as much as product quality — treatments should only be administered by appropriately registered and trained healthcare professionals.

Realistic expectations are important — genuine bio-remodellers offer gradual, natural-looking improvements in skin quality, not dramatic transformations.

A professional consultation is the most reliable starting point for anyone considering bio-remodelling treatments.

The growing popularity of bio-remodelling treatments has created an unfortunate market for unregulated, counterfeit, and poorly manufactured products that mimic the appearance and language of genuine clinical grade injectables. For patients researching skin rejuvenation options, understanding the distinction between these products is a matter of both safety and informed decision-making.

Genuine clinical grade bio-remodellers are distinguished by their regulatory status, pharmaceutical manufacturing standards, transparent manufacturer identity, published clinical evidence, and the requirement for qualified practitioners to administer them. Salon copies, counterfeit products, and grey-market alternatives cannot offer these assurances — and may present meaningful risks to patient safety.

When researching any injectable treatment, patients are encouraged to prioritise practitioner qualification, clinic registration, product transparency, and realistic outcome discussions over price alone. A thorough professional consultation remains the most reliable foundation for any aesthetic treatment pathway. For patients planning treatment timing around social events, reviewing post-Profhilo aftercare guidance can support safer expectations.

Treatment suitability, risks, and expected outcomes should always be assessed individually during a professional consultation.